Pentwater Capital Management’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Pentwater Capital Management’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,135,000	Closed	-$75.6M	–	174
2023 Q1	$75.6M	Buy	+3,135,000	New	+$39.3M	0.73%	29
2021 Q2	–	Sell	-10,000	Closed	-$105K	–	386
2021 Q1	$105K	Buy	+10,000	New	+$141K	﹤0.01%	332
2019 Q4	–	Sell	-20,000	Closed	-$137K	–	186
2019 Q3	$137K	Buy	+20,000	New	+$202K	﹤0.01%	153

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Pentwater Capital Management's PRVB Position: Q2 2023 in Review

Pentwater Capital Management sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 3,135,000 shares — an estimated $75.6M sold.

Pentwater Capital Management first reported a position in PRVB in Q3 2019 and held it in 3 quarters. The position peaked at $75.6M in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Pentwater Capital Management reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Pentwater Capital Management sold 3,135,000 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $75.6M.
Pentwater Capital Management first reported a position in Provention Bio, Inc. Common Stock in Q3 2019 and held it in 3 quarters.
Pentwater Capital Management's Provention Bio, Inc. Common Stock position peaked at $75.6M in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Pentwater Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.